CA2238723A1 - Arylethenesulfonamide derivatives and drug composition containing the same - Google Patents
Arylethenesulfonamide derivatives and drug composition containing the sameInfo
- Publication number
- CA2238723A1 CA2238723A1 CA002238723A CA2238723A CA2238723A1 CA 2238723 A1 CA2238723 A1 CA 2238723A1 CA 002238723 A CA002238723 A CA 002238723A CA 2238723 A CA2238723 A CA 2238723A CA 2238723 A1 CA2238723 A1 CA 2238723A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- atom
- substituted
- optionally substituted
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
(see formula I) Novel arylethenesulfonamide derivative having a high affinity for drugs, especially endoserine receptors, and represented by general formula (I); pharmaceutically acceptable salts thereof; and drugs comprising the same as the active ingredient, especially endoserine receptor antagonist, wherein Ar: optionally substituted aryl group or optionally substituted five- to six-membered heteroaryl group;
X: oxygen atom, sulfur atom or a group represented by a formula -NH-;
Y: oxygen atom or sulfur atom;
R1: hydrogen atom, optionally halogen-substituted lower alkyl group, cycloalkyl group, optionally substituted aryl group or optionally substituted five- to six-membered heteroaryl group;
R2: lower alkyl group, lower alkenyl group or lower alkynyl group where each of which may be substituted with one to three substituent(s) selected from a group consisting of hydroxyl group, lower alkoxy group, cycloalkyl group, halogen atom, carboxyl group and lower alkoxycarbonyl group;
R3: phenyl group which may be substituted with one to four substituent(s) selected from a group consisting of optionally halogen-substituted lower alkyl group, lower alkoxy group, halogen atom, lower alkylthio group, lower alkylsulfinyl group, lower alkanesulfonyl group, carboxyl group, lower alkoxycarbonyl group and carbamoyl group; and R4 and R5: they may be same or different and each is hydrogen atom or lower alkyl
X: oxygen atom, sulfur atom or a group represented by a formula -NH-;
Y: oxygen atom or sulfur atom;
R1: hydrogen atom, optionally halogen-substituted lower alkyl group, cycloalkyl group, optionally substituted aryl group or optionally substituted five- to six-membered heteroaryl group;
R2: lower alkyl group, lower alkenyl group or lower alkynyl group where each of which may be substituted with one to three substituent(s) selected from a group consisting of hydroxyl group, lower alkoxy group, cycloalkyl group, halogen atom, carboxyl group and lower alkoxycarbonyl group;
R3: phenyl group which may be substituted with one to four substituent(s) selected from a group consisting of optionally halogen-substituted lower alkyl group, lower alkoxy group, halogen atom, lower alkylthio group, lower alkylsulfinyl group, lower alkanesulfonyl group, carboxyl group, lower alkoxycarbonyl group and carbamoyl group; and R4 and R5: they may be same or different and each is hydrogen atom or lower alkyl
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPHEI-7-332111 | 1995-12-20 | ||
JP33211195 | 1995-12-20 | ||
PCT/JP1996/003701 WO1997022595A1 (en) | 1995-12-20 | 1996-12-19 | Arylethenesulfonamide derivatives and drug composition containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2238723A1 true CA2238723A1 (en) | 1997-06-26 |
CA2238723C CA2238723C (en) | 2006-06-13 |
Family
ID=36587553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002238723A Expired - Fee Related CA2238723C (en) | 1995-12-20 | 1996-12-19 | Arylethenesulfonamide derivatives and drug composition containing the same |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2238723C (en) |
-
1996
- 1996-12-19 CA CA002238723A patent/CA2238723C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2238723C (en) | 2006-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145192A0 (en) | Pyrimidine compounds | |
AU1171097A (en) | Arylethenesulfonamide derivatives and drug composition containing the same | |
PT1286998E (en) | OXAZOLIDINONE DERIVATIVES WITH ANTIBIOTIC ACTIVITY | |
CA2262502A1 (en) | 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same | |
WO2001009103A3 (en) | Imidazole antiproliferative agents | |
DE69021472D1 (en) | Pyrazole derivatives, processes for their preparation and pharmaceutical compositions containing them. | |
CA2237005A1 (en) | Quinazoline derivatives | |
DE69505968T2 (en) | AZOLIDINDION DERIVATIVES AND THEIR USE AS ANTI-HYPERGLYCEMAS | |
AU5910996A (en) | Pyrrole derivatives and medicinal composition | |
IL125982A0 (en) | 2-(arylphenyl) amino-imidazoline derivatives | |
EP1537879A4 (en) | Preventive and/or therapeutic drugs for asthma | |
CA2238723A1 (en) | Arylethenesulfonamide derivatives and drug composition containing the same | |
CA2382654A1 (en) | Novel a-500359 derivatives | |
CA2088702A1 (en) | Aminobenzoic acid derivatives | |
ATE170851T1 (en) | GUANIDINOTHIAZOLE DERIVATIVES AND THEIR USE AS H2 RECEPTOR ANTAGONISTS | |
EP1219619A4 (en) | Piperidine derivatives | |
MX9806341A (en) | Heterocyclyl-ergoline derivatives as 5-ht1a receptor ligands. | |
EP1352906A4 (en) | Compositions for prevention or treatment of hepatopathy | |
PL377530A1 (en) | Imidazol derivatives having affinity for alpha 2 receptors activity | |
EP1227098A4 (en) | Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents | |
CA2129813A1 (en) | 5-aminoflavone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |